Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2023-03-14$2.01/sh−100,000$201,000→ 201,666 total
Footnotes (1)
- [F1]These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.